News Archive

June 17, 2026

Triveni Bio raises $65M ahead of upcoming readouts on eczema drugs

  • Portfolio Company News
Read more
June 10, 2026

Ethyreal lands $101M to treat both Graves’ and thyroid eye disease

  • Portfolio Company News
Read more
June 8, 2026

Biotech’s Most Effective Medicine: No FDA Approval Required

  • From the Trenches
Read more
June 2, 2026

Patient-first, America-first: The Case For Global Collaboration

  • LifeSciVC
Read more
April 30, 2026

Year One as CEO: What Leadership Actually Feels Like

  • From the Trenches
Read more